Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Argus Health
Accenture
Harvard Business School
Fuji
Daiichi Sankyo
Moodys
US Department of Justice
Cantor Fitzgerald

Generated: February 18, 2019

DrugPatentWatch Database Preview

Litigation for KEYTRUDA

« Back to Dashboard

Patent Trial and Appeal Board Cases for KEYTRUDA

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
9,855,302 Genome & Company ➤ Try a Free Trial 2018-10-02 2018-10-02 Gajewski et al Post-grant review ➤ Try a Free Trial ➤ Try a Free Trial
Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
Colorcon
Fish and Richardson
Citi
Argus Health
McKinsey
Accenture
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.